USPTO serial 85583430
MASE
Reviewed by CopyMark Law Group
Reg. 4861676Status 710
- Filing date
- Status date
- Registration date
- Dec 1, 2015
- Examiner
- DAHLING, KRISTIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MASE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
4010 Basel, CH
4010 Basel, CH
HEIDELBERG, DE
HEIDELBERG, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole E. Gage
3000 K STREET N.W., SUITE 600WASHINGTON, DC 20007-5109UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer; data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data, comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments | SECTION 8 - CANCELLED | — |
| 042 | Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data, comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; providing medical and scientific research in the fields of pharmaceutical side effects genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, genomic data and genomic sequence analysis for scientific research purposes; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; software as a service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical research purposes; design and development of computer software in the fields of biology, medicine and bioinformatics; design and development of computer software for the integration of patient specific data, molecular test results, clinical studies and scientific results; medical and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others | SECTION 8 - CANCELLED | — |
| 044 | Providing an online database featuring diagnostic and therapeutic medical, pharmaceutical and genomic information; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to the treatment of individual patients; medical and pharmaceutical consulting services in relation to patient medical treatment options and treatment protocols | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Molecular Health AG
- Other trademarks owned by Molecular Health AG
- Other trademarks owned by MOLECULAR HEALTH GMBH
- Other trademarks owned by MOLECULAR HEALTH GMBH
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MASE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 17, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 1, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 1, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 28, 2015 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Oct 19, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 18, 2015 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Sep 18, 2015 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Sep 18, 2015 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 18, 2015 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 23, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 22, 2015 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 22, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 18, 2015 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 18, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 19, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 17, 2014 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 17, 2014 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 17, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 20, 2014 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 18, 2014 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 21, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 21, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 17, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 13, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 13, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 13, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 13, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 13, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 31, 2013 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 31, 2013 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 31, 2013 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 30, 2013 | DMCC | DATA MODIFICATION COMPLETED | — |
| Oct 2, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 1, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 1, 2013 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 26, 2013 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 24, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 12, 2013 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 12, 2013 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 12, 2013 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 11, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 11, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 11, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 11, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 5, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 5, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 5, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 5, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 30, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 22, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jan 22, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jan 18, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 18, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 4, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2012 | NWAP | NEW APPLICATION ENTERED | — |